Farms.com Home   News

Niagara grapevines well-poised for fruitful growing season

With the first day of spring officially here and temperatures already hovering around 20° C, Niagara grape growers will be keeping a close eye on the temperature swings predicted in the weather forecast.

Jim Willwerth, Brock University assistant professor of biological sciencessays that grapevines in the region have overwintered well. 

Growers’ attentions have now turned to being mindful of spring’s warmer daytime temperatures which can threaten the cold tolerance those vines built up during the winter dormancy period.

That’s because large fluctuations can also increase the threat of injury to buds, he says.

“Right now, our vines are staying winter hardy, the risk is that if we start getting very warm daytime temperatures in March, they might then lose hardiness quite rapidly,” says Willwerth.

Willwerth’s research conducted with Brock’s Cool Climate Oenology and Viticulture Institute (CCOVI) focuses on climate change and vine resiliency.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.